Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse] 임정요 2025.07.08 오전 07:59 HyundaiBio·HyundaiADM First to Identify Penetrium Pseudo Resistance Research Accepted by AACR 신민준 2025.08.29 오후 12:25 Hyundai Bioscience Initiates Global Phase 2/3 Trial of COVID-19 Treatment Xafty 유진희 2025.05.23 오후 02:08 Hyundai Bioscience Nears Launch of Phase 2·3 Dengue Trial...High Ranking Vietnamese Officials Ga... 유진희 2026.03.05 오후 12:00 Hyundai Bio·Hyundai ADM Hit Upper Limit as Clinical Trials Move into Full Swing[K-Bio Pulse] 신민준 2026.02.24 오전 08:00 MediPost hits limit on Japan valuation...Hyundai Bio rallies[K-Bio Pulse] 송영두 2026.01.28 오전 08:00 Hyundai Bioscience vows to license out Korea’s first antiviral 유진희 2025.05.19 오전 09:02 i-Sens Soars 23% on EU CGM Expansion [K-bio pulse] 김진수 2026.02.13 오전 08:10 Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse] 송영두 2025.07.13 오전 09:50 HyundaiBio begins global trials of universal antiviral drug 유진희 2025.04.23 오후 04:28 더 보기 로딩중..
HyundaiBioscience
HyundaiBioscience
![Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25070800251b.jpg)
![Hyundai Bio·Hyundai ADM Hit Upper Limit as Clinical Trials Move into Full Swing[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26022400248b.jpg)
![MediPost hits limit on Japan valuation...Hyundai Bio rallies[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/01/PS26012800269b.jpg)
![i-Sens Soars 23% on EU CGM Expansion [K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26021300327b.jpg)
![Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25071300087b.jpg)
